Home > News > Dog Virus Nanoparticles Adapted for Tumor Targeting
March 9th, 2006
Dog Virus Nanoparticles Adapted for Tumor Targeting
Abstract:
Writing in the Journal of Nanobiotechnology, a team led by Marianne Manchester, Ph.D., describes its studies aimed at determining whether mass-produced, non-infectious canine parvovirus nanoparticles might be suitable as a tumor-targeting drug delivery vehicle through the particles’ natural interaction with transferrin, a receptor that carries iron into cells. The reproducible size and chemical makeup of virus-based nanoparticles, combined with the relative ease of manufacturing them in large quantities, make them possible winners in the drive to develop nanoparticulate drug carriers for cancer therapy. Such laudable properties are only of use, however, if these protein nanoparticles can be modified to carry small molecules into tumor cells.
Source:
nano.cancer.gov
Related News Press |
Possible Futures
Nanoscale CL thermometry with lanthanide-doped heavy-metal oxide in TEM March 8th, 2024
Nanomedicine
High-tech 'paint' could spare patients repeated surgeries March 8th, 2024
Researchers develop artificial building blocks of life March 8th, 2024
Announcements
What heat can tell us about battery chemistry: using the Peltier effect to study lithium-ion cells March 8th, 2024
Nanoscale CL thermometry with lanthanide-doped heavy-metal oxide in TEM March 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||